These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9444524)

  • 1. In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
    Izumi H; Kawahara J; Takeuchi A; Izawa T; Ogawa N
    Fundam Clin Pharmacol; 1997; 11(6):561-6. PubMed ID: 9444524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery.
    Izumi H; Tanaka Y; Okada Y; Ogawa N; Izawa T
    Gen Pharmacol; 1996 Sep; 27(6):985-9. PubMed ID: 8909979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.
    Kawahara J; Izumi H; Okada Y; Izawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive properties of KRN4884, a novel long-lasting potassium channel opener.
    Kawahara J; Kashiwabara T; Ogawa N; Okada Y; Izawa T
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):292-4. PubMed ID: 10028939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery.
    Okada Y; Yokoyama T; Jinno Y; Kashiwabara T; Izawa T; Fukushima H; Ogawa N
    Eur J Pharmacol; 1993 Sep; 241(2-3):177-81. PubMed ID: 8243553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyanoamidines. II. Synthesis and pharmacological activity of N-arylalkyl-N'-cyano-3-pyridinecarboxamidines.
    Nakajima T; Nakajima S; Izawa T; Kashiwabara T; Munezuka Y
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2483-90. PubMed ID: 7697763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of coronary dilating effects of Ki1769, a new K channel opener of the pyridinecarboximidamide type, and nifedipine in anesthetized dogs.
    Yokoyama T; Kaneta S; Miwa A; Tanaka Y; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):194-203. PubMed ID: 7979828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of KRN4884 (a novel K+ channel opener), levcromakalim, nilvadipine and propranolol on endothelin-1-induced heart disorders in anesthetized rats.
    Harada K; Kawahara J; Okada Y; Uzumaki H; Kusaka M; Tokiwa T
    Jpn J Pharmacol; 1998 Nov; 78(3):261-8. PubMed ID: 9869259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative vasodepressor effects of 3-pyridine derivatives possessing the cyanoamidine or amide structure in pithed rats.
    Kashiwabara T; Nakajima T; Hasegawa S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 328(3):297-306. PubMed ID: 7625884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
    Kawahara J; Jinno Y; Endo M; Izumi H; Takeuchi A; Izawa T
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):814-9. PubMed ID: 9234664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cardiac ATP-sensitive K+ channels by KRN4884, a novel K+ channel opener.
    Shinbo A; Ono K; Iijima T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):770-7. PubMed ID: 9353397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KRN4884, a novel K+ channel opener, on ionic currents in rabbit femoral arterial myocytes.
    Muraki K; Sasaoka A; Ohya S; Watanabe M; Imaizumi Y
    J Pharmacol Sci; 2003 Nov; 93(3):289-98. PubMed ID: 14646246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the K+ channel opener KRN4884 on the cardiovascular metabolic syndrome model in rats.
    Okada Y; Yoshino T; Takeuchi A; Endoh M; Ohta H; Jinno Y; Yokoyama T; Izawa T; Kobayshi E
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):287-93. PubMed ID: 10672863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
    Yokoyama T; Okada Y; Jinno Y; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):941-5. PubMed ID: 7835641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and vasorelaxant effects on KRN2391 in spontaneously hypertensive rats.
    Kashiwabara T; Okada Y; Ogawa N; Fukushima H
    Gen Pharmacol; 1994 May; 25(3):487-94. PubMed ID: 7926595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of SCA40, a novel potassium channel opener, in rats.
    Michel A; Laurent F; Bompart J; Hadj-Kaddour K; Chapat JP; Boucard M; Bonnet PA
    Br J Pharmacol; 1993 Nov; 110(3):1031-6. PubMed ID: 8298791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.